Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-04-30

European debates on biotechnology: dimensions of public concern

Obiettivo



This proposal aims to uncover the moral and practical dimensions of concern that contribute to differing public attitudes towards current biotechnological applications across the European Union.
The last twenty years have seen rapid developments in modern biotechnology. In a relatively short time span basic research has led to a range of applications in a variety of areas including medical diagnostics and treatment, agriculture and food and environmental remediation. With these developments modern biotechnology has reached a new phase of relative maturity. This phase is characterised by a shift in the focus of regulatory attention, media coverage and public concern, away from the novel research techniques involving recombinant DNA (captured in the phrase "gene technology") and towards the assessment of particular products and services.
The recent 1996 Eurobarometer Survey on biotechnology suggests that public perceptions of modern biotechnology are increasingly differentiated with respect to areas of application. The survey clearly indicates that levels of public support are contingent upon the nature of the application under consideration: in general, medical and pharmaceutical applications are strongly supported, agricultural applications receive a mixed response, and transgenic animal applications receive are widely opposed. Underlying these different levels of support for particular appplications are judgements about the relative" usefulness" of these applications to society and the extent to which these applications are judged to be "morally acceptable". Surprisingly, the 1996 Eurobarometer results suggest that considerations of risk and safety do not influence levels of public support. Another key finding from the 1996 survey is the general lack of trust in the institutions responsible for regulating modern biotechnology in Europe.
These findings from the Eurobarometer survey find echoes in the concerns of those responsible for the successful development of a European biotechnology industry. There is increasing concerned amongst policy-makers themselves about the ethical issues raised by new biotechnological products and services, and about the role of transparency in securing public confidence and trust in the regulatory process.
We wish to conduct collaborative research designed to explore the moral and practical dimensions of public concern with respect to current applications of modern biotechnology. The proposal is for a set of inter-related research activities which will be funded nationally, but developed and coordinated through a Concerted Action. This Concerted Action is designed to build upon the expertise which has developed among the research partners participating in a previous project, and which includes invaluable background information in the form of systematic time series data on the development of public policy and media coverage from 1973 to 1996. The partners now possess a considerable expertise in the conduct of such research, and are widely recognised as a serious network of active European researchers investigating public perceptions of biotechnology.

Campo scientifico (EuroSciVoc)

CORDIS classifica i progetti con EuroSciVoc, una tassonomia multilingue dei campi scientifici, attraverso un processo semi-automatico basato su tecniche NLP. Cfr.: Il Vocabolario Scientifico Europeo.

È necessario effettuare l’accesso o registrarsi per utilizzare questa funzione

Programma(i)

Programmi di finanziamento pluriennali che definiscono le priorità dell’UE in materia di ricerca e innovazione.

Argomento(i)

Gli inviti a presentare proposte sono suddivisi per argomenti. Un argomento definisce un’area o un tema specifico per il quale i candidati possono presentare proposte. La descrizione di un argomento comprende il suo ambito specifico e l’impatto previsto del progetto finanziato.

Dati non disponibili

Invito a presentare proposte

Procedura per invitare i candidati a presentare proposte di progetti, con l’obiettivo di ricevere finanziamenti dall’UE.

Dati non disponibili

Meccanismo di finanziamento

Meccanismo di finanziamento (o «Tipo di azione») all’interno di un programma con caratteristiche comuni. Specifica: l’ambito di ciò che viene finanziato; il tasso di rimborso; i criteri di valutazione specifici per qualificarsi per il finanziamento; l’uso di forme semplificate di costi come gli importi forfettari.

CSC - Cost-sharing contracts

Coordinatore

National Museum of Science and Industry
Contributo UE
Nessun dato
Indirizzo
Exhibition Road
SW7 2DD London
Regno Unito

Mostra sulla mappa

Costo totale

I costi totali sostenuti dall’organizzazione per partecipare al progetto, compresi i costi diretti e indiretti. Questo importo è un sottoinsieme del bilancio complessivo del progetto.

Nessun dato

Partecipanti (1)

Il mio fascicolo 0 0